QLIFE — Qlife Holding AB Share News
0.000.00%
- SEK50.97m
- SEK53.05m
- SEK0.32m
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million
Brief: Qlife Holding Says Last Day Of Trading With BTA Is 8 April 2026
Brief: Qlife Announces Outcome Of Rights Issue, Resolves On Directed Issue
Brief: Qlife Says Hipro To Accelerate Egoo Development, Regulatory Approval In China
Brief: Qlife Publishes Information Document For SEK 31.4 Million Rights Issue
Brief: Qlife Launches Pharmacy Pilot Project In Nordic Markets
Brief: Qlife Holding To Hold EGM On Feb 26
Brief: Qlife Submits Egoo PHE For Regulatory Approval
Brief: Qlife Launches SEK 31.4 Mln Rights Issue
Brief: Egoo Health Says Breakthrough Precision In Diabetes Biomarker Test
Brief: Qlife, Hipro Sign Exclusive Commercial Agreement
Brief: Qlife Extends LoI For Reverse Takeover With Hipro
Brief: "Red Chip" Structure Says It Will Not Be Approved By Nasdaq, Other Structures Are Pursued
Brief: Qlife Q3 EBITDA SEK -6.398 Million
Brief: Qlife And Hipro Advance Heart Failure Tests Into Clinical Trials
Brief: Qlife Q2 EBITDA SEK -4.899 Million